Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)
Recruiting
N/A
Interventional Study
Heart Failure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 50 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 820 (estimated)
- Sponsor
- Baker Heart and Diabetes Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective study in which a process of identifying and improving a reduction of functional capacity in COVID-19 survivors \>50 years old. The overall goal of this study to identify the feasibility and value of risk-guided medical therapy and exercise intervention in COVID-19 survivors.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. History of COVID-19 infection
2. Live within a geographically accessible area for follow-up
Exclusion Criteria:
1. Valvular stenosis or regurgitation of \>moderate severity
2. History of previous heart failure (baseline New York Heart Association (NYHA) classification \>2)
…
Contacts